Chatterjee Mitali

Chatterjee is a Retired Professor of Pharmacology, IPGME&R, Kolkata, India, and presently an Emeritus Scientist at ICMR-NIRBI, Kolkata. Upon completing her MBBS and MD from University of Calcutta, she received her PhD from Jadavpur University, Kolkata, India. Her work as a medical immunopharmacologist includes multiple aspects of Leishmania biology that includes (i) delineating the immunopathology of Post Kala-azar Dermal Leishmaniasis (PKDL), a disease unique to South Asia, and especially challenging as it has no animal model; (ii) development of diagnostic/prognostic objective molecular tools for monitoring anti-leishmanial therapy and (iii) studying redox-dysfunction as an effective leishmanicidal approach. In sum, the thrust of Chatterjee’s work is translational research in Indian Leishmaniasis with a view towards facilitating a greater understanding of disease pathogenesis through worldwide collaborations across geographic borders, as also supporting the ongoing kala-azar elimination programme. She is a member of four Indian Science academies and has over 175 publications in leading International journals, Clin Infect Dis, J Invest Dermatol, J Clin Invest, J Inf Dis, PLoS NTD